Cancer is a complex biological disease in which normal cellular regulatory mechanisms become progressively disrupted. As a result, cells acquire abnormal behaviors that promote uncontrolled growth, survival, and spread within the body.
To explain these shared behaviors across different cancer types, the hallmarks of cancer framework was proposed by Douglas Hanahan and Robert A. Weinberg. This model defines the key biological capabilities that cancer cells acquire during tumor development.
In this article, we will examine the hallmarks of cancer from a tumor biology perspective, highlighting how they drive tumor initiation, progression, and malignancy.
I. The Concept of the Hallmarks of Cancer
1. Why Cancer Cells Are Different from Normal Cells
In normal tissues, cell behavior is precisely regulated by a network of signaling pathways that control proliferation, differentiation, and cell death. These regulatory systems ensure that cells divide only when necessary and stop growing when tissue integrity is achieved. Cancer cells fundamentally differ from normal cells because they lose this tight growth control.
One of the earliest changes in tumor development is the disruption of growth-regulatory mechanisms. Cancer cells become insensitive to signals that normally limit cell division, such as contact inhibition and growth-suppressive cues from neighboring cells. At the same time, they gain the ability to generate or amplify growth-promoting signals, allowing them to proliferate autonomously.
During tumor evolution, cancer cells also acquire survival advantages that enable them to persist under unfavorable conditions. These advantages include resistance to programmed cell death, tolerance to genomic damage, and the ability to survive in low-oxygen or nutrient-poor environments. Through a process resembling natural selection, cells that best adapt to these stresses are preferentially retained, driving progressive tumor growth and malignancy.
2. Evolution of the Hallmarks Framework
The hallmarks of cancer framework was originally introduced to organize the complex and rapidly expanding knowledge of cancer biology into a coherent model. The initial version described six core biological capabilities that were considered essential for malignant transformation. These hallmarks captured the fundamental processes underlying tumor growth and dissemination.
As cancer research advanced, it became clear that additional biological traits play critical roles in tumor progression. This led to the expansion of the framework to include emerging hallmarks, such as metabolic reprogramming and immune evasion, as well as enabling characteristics that facilitate the acquisition of all hallmarks. Genome instability and chronic inflammation were recognized as key forces that accelerate tumor evolution by increasing genetic diversity and shaping the tumor environment.
This evolution of the hallmarks model reflects a shift from a purely cancer cell–centric view to a more integrated understanding of cancer as a complex biological system. The framework continues to evolve as new mechanisms and interactions are discovered, reinforcing its relevance in modern tumor biology.
3. Hallmarks of Cancer and the Tumor Microenvironment
Cancer cells do not exist in isolation. They are embedded within a complex tumor microenvironment composed of stromal fibroblasts, immune cells, endothelial cells, and extracellular matrix components. This environment plays an active role in shaping how cancer hallmarks are expressed and maintained.
Interactions between cancer cells and stromal cells can promote tumor growth by providing growth factors, survival signals, and structural support. Immune cells within the tumor microenvironment may exert anti-tumor effects, but cancer cells often develop strategies to suppress or evade immune surveillance. At the same time, vascular cells contribute to angiogenesis, supplying oxygen and nutrients that sustain tumor expansion.
The hallmarks of cancer therefore emerge not only from intrinsic cellular alterations but also from dynamic interactions with the surrounding microenvironment.
II. The Core Hallmarks of Cancer
The core hallmarks of cancer describe the fundamental biological capabilities that cancer cells must acquire to grow, survive, and spread. These hallmarks form the backbone of the cancer phenotype and are observed, in one form or another, across most human tumors.
Hallmarks of Cancer
- Sustaining proliferative signaling
- Evading growth suppressors
- Resisting cell death
- Enabling replicative immortality
- Inducing angiogenesis
- Activating invasion and metastasis
- Deregulating cellular energetics (emerging hallmark)
- Avoiding immune destruction (emerging hallmark)
- Genome instability and mutation (enabling characteristic)
- Tumor-promoting inflammation (enabling characteristic)
1. Sustaining Proliferative Signaling
Normal cells require tightly regulated external signals to initiate cell division. In contrast, cancer cells develop the ability to sustain continuous proliferative signaling. They achieve this by producing their own growth signals, increasing the expression or activity of growth factor receptors, or activating downstream signaling pathways independently of external cues.
This persistent stimulation drives uncontrolled cell cycle progression and allows cancer cells to divide even in environments where normal cells would remain quiescent. Sustained proliferation is a defining feature of tumor growth and a critical early step in cancer development.
2. Evading Growth Suppressors
In healthy tissues, growth suppressor mechanisms act as brakes on cell division. These systems monitor cell density, tissue architecture, and genomic integrity, halting proliferation when abnormalities are detected. Cancer cells bypass these safeguards by disabling growth-inhibitory pathways.
The loss of growth suppressor function removes critical checkpoints that normally prevent inappropriate cell division. As a result, cancer cells continue to proliferate despite signals that would normally trigger cell cycle arrest or cellular senescence.
3. Resisting Cell Death
Programmed cell death is an essential protective mechanism that eliminates damaged or abnormal cells. Cancer cells acquire the ability to resist cell death, allowing them to survive conditions that would normally be lethal, such as DNA damage, oncogenic stress, or nutrient deprivation.
By avoiding cell death, cancer cells accumulate further genetic alterations and persist within hostile microenvironments. This resistance contributes to tumor progression and is a major factor in treatment resistance.
4. Enabling Replicative Immortality
Normal cells have a limited capacity to divide, eventually entering a state of permanent growth arrest. Cancer cells overcome this limitation and achieve replicative immortality, enabling them to undergo unlimited rounds of cell division.
This hallmark allows tumors to expand indefinitely and maintain long-term growth. Replicative immortality is essential for the formation of large, clinically detectable tumors.
5. Inducing Angiogenesis
As tumors grow, their demand for oxygen and nutrients increases. Cancer cells stimulate the formation of new blood vessels through a process known as angiogenesis. This newly formed vascular network supplies the tumor with essential resources and removes metabolic waste.
Angiogenesis not only supports tumor growth but also provides a route for cancer cells to enter the circulation, facilitating metastatic spread.
6. Activating Invasion and Metastasis
The ability to invade surrounding tissues and form distant secondary tumors is a hallmark of malignant cancer. Cancer cells acquire invasive properties that allow them to detach from the primary tumor, degrade extracellular barriers, and migrate into neighboring tissues.
Once cancer cells enter the bloodstream or lymphatic system, they can colonize distant organs and establish metastases. This process is responsible for the majority of cancer-related deaths and represents the most clinically dangerous aspect of cancer progression.
III. Emerging Hallmarks of Cancer
As research in tumor biology expanded, it became clear that the original hallmarks did not fully capture the complexity of cancer. This led to the recognition of emerging hallmarks, which reflect additional capabilities that cancer cells acquire to support growth, survival, and progression within the host.
1. Deregulating Cellular Energetics
Normal cells primarily rely on efficient mitochondrial oxidative phosphorylation to generate energy. In contrast, cancer cells frequently reprogram their metabolism to support rapid growth and biosynthesis. This metabolic shift allows cancer cells to meet the increased demands for energy and molecular building blocks required for continuous proliferation.
By favoring less efficient but faster metabolic pathways, cancer cells can adapt to fluctuating oxygen levels and nutrient availability. This deregulation of cellular energetics is now recognized as a central feature of tumor biology and a potential vulnerability for therapeutic intervention.
2. Avoiding Immune Destruction
The immune system plays a critical role in detecting and eliminating abnormal cells. Emerging evidence shows that cancer cells actively develop strategies to avoid immune recognition and destruction. These mechanisms allow tumors to persist and grow despite the presence of immune surveillance.
Cancer cells may alter antigen presentation, suppress immune cell activation, or create an immunosuppressive microenvironment that favors tumor survival. By escaping immune control, cancer cells gain a significant survival advantage, enabling long-term tumor maintenance and progression.
These emerging hallmarks highlight the dynamic interaction between cancer cells and their metabolic and immune environments. Together with the core hallmarks, they provide a more complete picture of the biological strategies that underlie malignant transformation.
IV. Enabling Characteristics of Cancer
While the hallmarks of cancer describe the key biological capabilities acquired by tumor cells, these traits do not arise spontaneously. Instead, they are facilitated by underlying processes known as enabling characteristics. These characteristics create a cellular and tissue environment that accelerates tumor evolution and supports the acquisition of multiple hallmarks.
1. Genome Instability and Mutation
Genomic integrity is essential for normal cellular function. In cancer, this stability is often compromised, leading to an increased rate of mutations and chromosomal alterations. Defects in DNA repair mechanisms, cell cycle checkpoints, and chromosome segregation contribute to the accumulation of genetic abnormalities.
Genome instability generates a diverse population of cancer cells within a tumor. This diversity increases the likelihood that some cells will acquire advantageous traits, such as resistance to cell death or enhanced proliferative capacity. As a result, genome instability acts as a driving force behind tumor progression and therapeutic resistance.
2. Tumor-Promoting Inflammation
Chronic inflammation is now recognized as a key enabling characteristic of cancer. Inflammatory cells and mediators within the tumor microenvironment can promote tumor growth by stimulating cell proliferation, enhancing survival signals, and inducing angiogenesis.
Inflammation also contributes to genomic instability by generating reactive molecules that damage DNA. Rather than eliminating cancer cells, persistent inflammatory responses often create conditions that favor tumor development and progression. This close relationship between inflammation and cancer highlights the importance of the tissue environment in shaping malignant behavior.
Together, genome instability and tumor-promoting inflammation provide the fertile ground upon which cancer hallmarks emerge. By accelerating genetic change and modifying the tumor microenvironment, these enabling characteristics play a central role in the biology of cancer.
Conclusion
The hallmarks of cancer provide a powerful biological framework for understanding how normal cells transform into malignant tumors. By identifying the shared capabilities that drive tumor initiation, progression, and metastasis, this model has reshaped modern tumor biology. Integrating core hallmarks, emerging traits, and enabling characteristics offers a comprehensive view of cancer as a dynamic and evolving disease, guiding both research and therapeutic strategies.
